Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07242391 · ClinicalTrials.gov registry record

Menopausal Hormone Therapy And Left Ventricular Function

A clinical trial, sponsored by Mayo Clinic.

Not yet
Registry status
50
Enrollment target

NCT07242391: Clinical Trial study, sponsored by Mayo Clinic.

NCT07242391 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07242391 has not yet begun recruiting, sponsored by Mayo Clinic.

NOT YET RECRUITING
Registry status
50 participants
Enrollment target

Study Summary

The purpose of this study is to compare left ventricular stroke volume and heart rate responses to bursts of SNA between PMF using, and not using, MHT.

Interventions

  • DRUG Menopausal Hormone Therapy

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-07
Est. Completion 2027-12

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT07242391

The ClinicalTrials.gov registry entry for NCT07242391 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Menopausal Hormone Therapy is the first listed.

NCT07242391 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07242391 about?

NCT07242391 is a clinical study titled "Menopausal Hormone Therapy And Left Ventricular Function". The purpose of this study is to compare left ventricular stroke volume and heart rate responses to bursts of SNA between PMF using, and not using, MHT.

What is the current status of trial NCT07242391?

This trial is currently not yet recruiting. The enrollment target is 50 participants. The study started on 2026-07. Estimated completion is 2027-12.

What interventions are being tested in trial NCT07242391?

The interventions under investigation include: Menopausal Hormone Therapy (DRUG).

Who is sponsoring clinical trial NCT07242391?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.